Investors

PHILADELPHIA, June 2, 2016 /PRNewswire/ -- EY today announced that Matthew Pauls, president and chief executive officer of Strongbridge Biopharma (NASDAQ: SBBP) is a finalist for the EY Entrepreneur Of The Year® 2016 Award in the Greater Philadelphia.

The awards program, which is celebrating its 30^th year, recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance and personal commitment to their businesses and communities. Mr. Pauls was selected as a finalist by a panel of independent judges. Award winners will be announced at a special gala on June 9th at the Terrace Ballroom, Pennsylvania Convention Center.

Now in its 30th year, the EY Entrepreneur Of The Year program has expanded to recognize business leaders in more than 145 cities in more than 60 countries throughout the world. 

Regional award winners are eligible for consideration for the EY Entrepreneur Of The Year National program. Award winners in several national categories, as well as the EY Entrepreneur Of The Year National Overall Award winner, will be announced at the EY Entrepreneur Of The Year National Awards gala in Palm Springs, California, on November 19, 2016. The awards are the culminating event of the EY Strategic Growth Forum®, the nation's most prestigious gathering of high-growth, market-leading companies.

Sponsors
Founded and produced by EY, the Entrepreneur Of The Year Awards are nationally sponsored by SAP America, Merrill Corporation and the Ewing Marion Kauffman Foundation.

In Greater Philadelphia, sponsors also include PNC Bank, Pine Hill Group, LLP, SolomonEdwards Group, Ballard Spahr LLP, Morgan Lewis, Pepper Hamilton LLP, Simkiss & Block and Philadelphia Business Journal.

About EY Entrepreneur Of The Year®
EY Entrepreneur Of The Year is the world's most prestigious business award for entrepreneurs. The unique award makes a difference through the way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 145 cities in more than 60 countries.

About EY's Strategic Growth Markets practice
EY's Strategic Growth Markets (SGM) practice guides leading high-growth companies. Our multidisciplinary teams of elite professionals provide perspective and advice to help our clients accelerate market leadership. SGM delivers assurance, tax, transactions and advisory services to thousands of companies spanning all industries. EY is the undisputed leader in taking companies public, advising key government agencies on the issues impacting high-growth companies and convening the experts who shape the business climate. For more information, please visit us at ey.com/us/strategicgrowthmarkets, or follow news on Twitter @EY_Growth.

About EY
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.

EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ey-announces-strongbridge-biopharmas-president-and-ceo-matthew-pauls-is-named-an-ey-entrepreneur-of-the-year-2016-finalist-in-greater-philadelphia-300278401.html

SOURCE Strongbridge Biopharma